How Much Does a Pharmacy Fitout Cost in Australia? (2026 Guide)

Pharmacy fitout costs are among the most variable in commercial healthcare design. The total investment for a new community pharmacy in a suburban shopping centre looks nothing like the cost of a specialist compounding pharmacy - and neither resembles what a remote Western Australian independent spends to open its doors. Getting a realistic budget expectation before you commit to a lease, an acquisition, or a refurbishment is one of the most useful things you can do at the planning stage.

This guide sets out realistic 2026 cost ranges for Australian independent pharmacies - by area, by pharmacy type, and by location - along with the market and regulatory context you need to make a sound investment decision right now. For a full breakdown by fitout element, see our pharmacy fitout costs page.

Quick answer: 2026 pharmacy fitout cost ranges

For early feasibility planning, costs are best understood per square metre. These figures reflect current market conditions across Australia:

  • Entry level: $1,500 - $1,900 per m²

  • Standard community pharmacy: $2,000 - $3,500 per m²

  • Specialist environments (sterile compounding): $4,000 - $6,000 per m²

  • Remote locations: up to $7,000 per m²

Community pharmacies in Australia typically range from around 50 m² to 500 m², with 150 m² being a common size for a metropolitan independent. At that size, a standard community pharmacy fitout generally falls between $300,000 and $450,000 - and that figure excludes automation, compounding infrastructure, and professional fees.

These are starting points, not builder quotes. The actual cost of your project depends on your tenancy's condition, your location, the services you plan to offer, and the level of specification you choose across each area. Each of these variables can move the final figure meaningfully in either direction.

Why pharmacy fitout costs differ from standard commercial fitouts

Walk into any empty retail tenancy and you see the same shell: concrete slab, bare ceiling, bare walls, a distribution board. A clothing retailer can fit that space with standard joinery, lighting, and a point-of-sale counter. A pharmacy cannot.

The dispensary alone is a different category of construction. It requires bespoke cabinetry built to workflow specifications, specialised safe and refrigeration infrastructure, dense electrical and data distribution, clinical sinks, and in many cases, provision for dispensing robotics. None of these are off-the-shelf components - they are designed, specified, and coordinated as part of a pharmacy-specific documentation package that no general commercial builder can produce without pharmacy design expertise behind it.

Regulatory requirements add layers that standard retail fitouts do not face. Community pharmacies require floor plans prepared to the requirements of the Australian Community Pharmacy Authority and your state pharmacy authority before the premises can trade. Building certification under the National Construction Code is required in most cases, with the pathway depending on the extent of works and the state. Security configurations are mandated - not discretionary.

The result is that even a modest pharmacy fitout carries a cost premium over retail of comparable size. That premium reflects genuine technical complexity. Working with a designer who understands pharmacy operations from the outset is the most direct way to manage it - by designing to the right specification the first time, rather than discovering gaps after the builder has priced and started.

Why 2026 is a significant year to make this decision

The Australian pharmacy sector has navigated real disruption over the past two years. The 60-day dispensing reform - rolled out across three stages from September 2023 to September 2024 - reduced dispensing volumes for pharmacies with a significant share of eligible chronic disease prescriptions. At its peak, the reform generated serious uncertainty about pharmacy viability.

The picture has now stabilised in ways that directly affect the investment case for a fitout.

The Eighth Community Pharmacy Agreement (8CPA), which commenced on 1 July 2024 and runs to 30 June 2029, provides five years of CPI-indexed remuneration certainty. The Additional Community Supply Support (ACSS) payment, doubled from 1 July 2025 to $1.57 per PBS claimable script, has substantially offset the dispensing revenue reduction from 60-day scripts for most pharmacies. The 8CPA also allocates $1.05 billion over five years for community pharmacy programs and professional services - which is where the design implications become most significant.

Pharmacist prescribing and expanded scope of practice are no longer pilots. They are government policy, moving into funded, permanent programs across multiple states. In Queensland, the Extended Practice Authority became permanent from 1 July 2025, allowing pharmacists to prescribe for UTIs and a broader set of acute conditions (PSA Queensland). In Victoria, the 2025-26 state budget committed $18 million to fund expanded pharmacist prescribing services (PSA Victoria). Expanded vaccination scope, consultation services, and prescribing pathways are open or advancing in Tasmania, South Australia, and other states. Every one of these funded services requires a private consultation space to deliver. A pharmacy without one cannot access the income streams that current government policy is directing funding toward.

There is also a cost-of-waiting argument that is harder to dismiss in 2026 than it was two years ago. Construction costs across Australia are rising at 4 to 6 per cent per year, with some markets tracking higher. Copper - which drives the cost of all electrical, plumbing, and mechanical services in a fitout - increased by more than 16 per cent over the past year, affecting services trade costs across every construction category. Labour shortages in the construction sector have extended project lead times, particularly in Queensland, Perth, and Adelaide. For an independent pharmacist in the planning phase, the financial case for acting now rather than deferring is clearer than it has been at any point since the 8CPA was negotiated.

Dispensary costs - the most expensive part of your fitout

The dispensary is where pharmacy fitout costs diverge most sharply from standard commercial construction. In a well-designed pharmacy, the dispensary typically occupies 20 to 30 per cent of the total floor area - but accounts for a disproportionate share of the budget, typically costing 30 to 60 per cent more per square metre than the retail floor.

The density of what goes into a dispensary is the driver. A compact dispensary space needs to accommodate all of the following:

  • Bespoke cabinetry designed around dispensing workflow and staff ergonomics

  • Specialised shelving and drawer systems for dispensary stock

  • Computer workstations with dedicated data and power infrastructure

  • One or more medical-grade refrigerators for cold-chain products

  • A controlled drugs safe and, in some cases, a vault

  • A clinical hand basin with appropriate plumbing

  • Extensive electrical distribution for computer and monitoring systems

  • Provision for automation - whether or not robotics are installed in the first stage

That last point deserves attention. Dispensing robots and pneumatic tube systems are among the highest individual cost items in a pharmacy fitout. They are also items that many independents want to defer until the business is more established. The right approach is to design the dispensary so that automation can be added without rebuilding the surrounding cabinetry and services - a decision that is only available at the design stage, not after the joinery is built and the slab is poured.

Even a straightforward dispensary specification carries a premium. There is no design decision that changes the fundamental density of the space - only poor decisions that increase it unnecessarily. What pharmacy-specific design does is ensure that density is configured efficiently, so the space works from opening day and can grow without waste.

Retail area costs - where flexibility lives

The retail floor is where an independent pharmacy has the most genuine flexibility in how it applies its fitout budget. The primary variable is the approach to shelving and display.

Standard metal gondola shelving is the most cost-effective retail option. It is modular, can be dismantled and relocated, and suits a wide range of product display configurations. For a pharmacy testing a new location, or working under capital constraints, gondola shelving in the retail area is a sound first-stage choice - it keeps initial costs down while the site establishes itself.

Custom joinery and feature display elements increase retail costs meaningfully. Bespoke countertops, curved fixtures, integrated lighting, and feature cabinetry create a differentiated customer experience - and a higher cost per square metre. For an established pharmacy investing in brand identity and patient experience, that premium is often well justified. For a first fitout in a new location, the retail area is the most sensible place to stage capital expenditure.

Retail areas also cost less per square metre to construct than dispensaries because they require less plumbing, allow for more economical flooring selections, and involve lower-density electrical and data services. That difference reinforces why the dispensary should always be the priority specification decision, with retail adjusted around the available budget.

Consultation room costs - from optional to essential

The consultation room is the most consequential shift in pharmacy design requirements over the past two years, and the most important element for an independent pharmacist to budget for in 2026.

Until recently, a consultation room was something pharmacies included when they had the space. The regulatory and funding environment has changed that. To deliver the pharmacist prescribing services now funded by state governments - permanently in Queensland, $18 million committed in Victoria, with pathways operating in Tasmania and others - a private consultation room is a prerequisite, not a feature. The Pharmacy Guild of Australia has made consultation room infrastructure a policy priority, with equipment and fitout support available to member pharmacies investing in this transition.

What a compliant consultation room requires is straightforward in principle: a private, acoustically separated space - typically 8 to 10 m² at minimum - with a clinical hand basin, an accessible door compliant with current NCC accessibility standards, adequate lighting, and a surface configuration that supports patient consultations. The defining requirement is privacy - a patient must not be audible from the retail floor.

The construction cost of a consultation room depends on the starting point. In a new fitout, a consultation room is simply a room in the plan - the most cost-effective way to include it. Retrofitting one into an existing pharmacy with no consultation space involves partition walls, acoustic treatment, possible ceiling works, plumbing for the hand basin, and coordination with the existing services layout. That scope is more involved, and therefore more expensive, than designing it in from the beginning.

Pharmacies planning a fitout or refurbishment in 2026 that do not include a consultation room are making a decision that will require them to spend more money to correct it later - at a time when their competitors with consultation rooms are already generating revenue from funded clinical services.

Compounding room costs

Compounding is a core service for many independent pharmacies, but the fitout requirements - and costs - vary dramatically depending on the type of compounding involved.

Non-sterile compounding

A purpose-built non-sterile, non-hazardous compounding room of 10 to 15 m² - covering walls, ceiling, door, cabinetry, sink, lighting, electrical works, and a general ventilation upgrade - typically costs $20,000 to $35,000 for the construction component. This cost range applies to projects where HVAC air classification, pressure differentials, and cleanroom validation are not required, which keeps costs well below sterile environments.

Specialist equipment - including HEPA-filtered powder containment cabinets, analytical balances, and temperature and humidity monitoring systems - is separate from and additional to the construction cost above.

The Pharmacy Board of Australia's revised guidelines on compounding of medicines, which took effect on 1 October 2024, introduced stricter requirements for compounding facilities across all categories. Pharmacies that compound must now conduct and document a formal risk assessment of their facilities before commencing any compounding activity. For a pharmacy planning a fitout that includes a compounding room, this risk assessment should inform the fitout scope from the beginning - not be conducted after the room is built.

Sterile compounding

Sterile compounding sits in a significantly different cost category. The physical infrastructure required for a compliant sterile compounding suite - ISO-classified cleanrooms with defined air classification grades, positive and negative pressure differentials, pass-through hatches, specialist surfaces, and a dedicated air handling system - pushes costs well above standard dispensary construction.

The HVAC system alone - covering a dedicated air handling unit, ductwork, HEPA or ULPA filtration, and the cooling infrastructure to maintain cleanroom conditions - commonly ranges from $25,000 to $70,000, with costs driven higher by increased air classification requirements and higher air change rates. This is before cleanroom construction, specialist equipment, environmental monitoring, and validation costs are accounted for.

Additional cost items for a sterile compounding suite include autoclaves, isolators or laminar airflow safety cabinets, water purification systems, pass-through hatches with interlocking door controls, electrical upgrades for clean power supply, and the validation and testing required to demonstrate that the facility meets TGA good manufacturing practice standards. For pharmacies performing hazardous sterile compounding - cytotoxic preparations, for example - the design and operational requirements are more stringent again.

It is also worth noting that from 1 October 2024, pharmacists can no longer compound GLP-1 receptor agonist analogues (including semaglutide analogues) for patient supply, following a TGA determination amending Schedule 5, Item 6 of the Therapeutic Goods Regulations. For any pharmacy that had been considering a sterile compounding investment on the basis of GLP-1 demand, that specific business case no longer applies.

For a closer look at how a compounding facility is designed around workflow and compliance, see our compounding lab design guide.

Security costs - what you cannot skip

Security is not discretionary in a pharmacy fitout. Australian pharmacies are classified premises under state drugs and poisons legislation, and both regulatory requirements and insurance obligations mandate a minimum level of physical security infrastructure regardless of pharmacy size or location.

A standard pharmacy security scope includes a monitored alarm system, tenancy perimeter protection, security grilles or roller shutters on all pharmacy access points, anti-vandal glazing film on shopfront glass, and a monitored CCTV system covering the dispensary, retail area, and all entry points. Where pharmacy authority or insurance requirements mandate it - and this is standard for pharmacies dispensing Schedule 8 controlled drugs above threshold quantities - a certified drug vault or strong room is also required.

Security costs vary with the size of the tenancy, the number of access points, the level of CCTV coverage, and whether vault installation is required. They are, however, non-negotiable budget line items. They cannot be deferred, cut, or treated as contingency in the way that retail joinery or feature lighting can be.

How location affects your budget

Location is one of the most significant variables in any pharmacy fitout budget, and the gap between metropolitan and remote costs is larger than most pharmacists expect when they first start planning.

Metropolitan pharmacies generally benefit from good subcontractor competition, reliable materials supply chains, and reasonable trade access. That said, demand pressure from major infrastructure projects is affecting contractor availability and pricing in several capital city markets. Current industry benchmarks point to cost escalation running at approximately 4 per cent per year in Sydney and Melbourne, and 5 per cent or more in Brisbane, Perth, and Adelaide - a difference that is worth factoring into timing decisions.

Regional pharmacies typically carry a 15 to 25 per cent cost premium over comparable metropolitan projects. Reduced trade availability, higher material freight costs, longer construction timelines, and subcontractor mobilisation costs all contribute. The further a project sits from a major trade centre, the more of these factors compound against the budget.

Remote pharmacies attract the largest cost premium - in some cases reaching $7,000 per m² or more. Limited contractor competition, travel and accommodation requirements for trades, freight surcharges on materials, and the potential need for utility upgrades - three-phase power, gas connections, water supply infrastructure - can all add substantially to the base construction cost. Remote pharmacies also face longer construction timelines, which adds to holding costs on vacant tenancies.

For any pharmacy outside a capital city, site-specific quoting is the only reliable way to budget. National benchmarks carry significant uncertainty when applied to regional and remote contexts, and early estimates should reflect that variability.

What the builder's quote does not include

One of the most consistent sources of budget surprises in pharmacy fitouts is the gap between the builder's construction quote and the total project cost. The builder's quote covers construction - and construction alone.

It does not include professional design fees. A pharmacy fitout requires a complete documentation package: initial layout and workflow design, three-dimensional visualisations for client decision-making, tender documentation that allows builders to price accurately and competitively, construction drawings for building permits or fitout certification, and pharmacy authority submission plans prepared to ACPA and state authority requirements. At Design Yard 32, we stay involved through the construction phase - answering builder queries and providing supplementary drawings when required - so these fees cover the full project arc, not just the design stage. A pharmacy that proceeds to construction without complete, coordinated documentation almost always pays more through variations and scope errors than it would have spent on thorough documentation in the first place.

Pharmacy equipment is also separate from construction. Dispensing robots and pneumatic tube systems, medical-grade refrigeration for cold-chain storage, safe installations, computer hardware, point-of-sale systems, and retail display fixtures are all supplied and installed outside the core fitout construction contract. For pharmacies investing in automation, this component can represent a significant additional budget line on top of the construction cost.

Building permits or fitout certification, engineering consultant fees where structural or essential services work is involved, planning permits for shopfront or signage works, and GMP validation for sterile compounding environments are all outside the builder's scope. The practical result is that the total project investment is typically 20 to 40 per cent above the construction quote - and for specialist environments, that margin is wider.

Staged fitouts - a practical strategy for independent pharmacists

A staged fitout is a legitimate and financially sensible approach for independent pharmacists in a range of situations: when testing a new location before over-committing capital, when opening a pharmacy that will grow as the patient base builds, or when the business case for specific infrastructure - a consultation room, a compounding suite, a dispensing robot - needs time to develop.

The critical condition for a staged fitout is that the staging must be designed from the beginning. A fitout designed with future staging in mind reserves the right wall locations for future partitions, runs electrical conduit to points where equipment will eventually be installed, positions the dispensary so that automation can be added without rebuilding surrounding cabinetry, and ensures the retail layout does not obstruct access to where a consultation room will go.

Retrofitting a feature that was not planned for from the outset almost always costs more than including it correctly in the first stage. The savings from a staged fitout come from deferring capital outlay - not from paying twice to reconstruct a space that was not designed for growth. At Design Yard 32, staged fitout planning for pharmacies testing new locations is a service we provide regularly, and the spatial logic of stage two is as important to get right at the design stage as stage one.

What commonly sends pharmacy budgets over estimate

Most pharmacy fitout cost overruns trace back to a small number of recurring causes.

Existing building conditions are the most common. Asbestos identified during demolition rather than in a pre-construction audit, termite damage behind existing wall linings, water ingress affecting structural elements, outdated plumbing requiring full replacement, and aged switchboards that cannot support the new fitout's electrical load - all of these are discovered during construction rather than before it, and all generate variations at a premium over what the work would have cost if scoped and priced at tender.

Documentation gaps are the second most common driver. When the drawings provided to the builder are incomplete - missing cabinetry details, uncoordinated structural and services layouts, absent specifications for materials and finishes - the builder fills in the blanks with variations. Pharmacy fitout quotes that appear attractively low frequently reflect thin documentation rather than a more efficient project. The gap shows up once construction starts.

Poor coordination between consultants compounds both problems. When the pharmacy layout designer, the HVAC engineer, and the electrical consultant are working from uncoordinated drawings, slab penetrations end up in the wrong locations, services clash in ceiling voids, and builders are asked to resolve on site what should have been resolved on paper. For cleanroom and compounding environments, where service coordination is critical to achieving the required pressure differentials and air classification, uncoordinated documentation is a particularly expensive problem.

For pharmacies incorporating automation or sterile compounding, under-specification of the infrastructure phase - slab load ratings, ceiling heights, electrical supply capacity, HVAC plant sizing - before that equipment is ordered and installed creates expensive retrofitting requirements that a complete design process would have avoided.

  • Cost depends on location, pharmacy size, and the services the fitout needs to support. A standard community pharmacy costs $2,000 to $3,500 per m² in a major metropolitan area, with a typical 150 m² metropolitan pharmacy falling between $300,000 and $450,000 for the construction component. Sterile compounding environments, remote locations, and heavily automated dispensaries all sit above this range. Design fees, equipment, and approvals are separate from these construction figures.

  • If you plan to deliver the pharmacist prescribing services now funded under state government programs - UTI treatment, expanded acute conditions, and the broader consultation services rolling out across Queensland, Victoria, Tasmania, and other states - you need a private consultation space to access those income streams. The requirement is a private, acoustically separated room with a clinical hand basin and an accessible entrance. Pharmacies without one are excluded from the funded services that current policy is directing investment toward.

  • The dispensary is consistently the most cost-intensive area, typically costing 30 to 60 per cent more per m² than the retail floor. The density of bespoke cabinetry, specialised storage, safes, cold chain refrigeration, data and electrical infrastructure, and automation provision makes it the most technically demanding construction zone in any pharmacy. Sterile compounding suites and dispensing robot installations represent the highest individual cost items in specialist pharmacy fitouts.

  • Yes. From 29 July 2025, the National Construction Code references AS 1428.1:2021 as the current standard for accessibility in commercial buildings, replacing the 2009 edition. Any pharmacy fitout submitted for building approval from that date must comply with the updated standard. The changes affect door and threshold geometry, ramp specifications, and sanitary fixture requirements. Drawings based on the 2009 edition will need updating before submission to avoid approval delays - something to confirm with your designer and building certifier early in the process.

  • The short-term revenue impact was real, but the situation has materially changed. The ACSS payment, doubled from 1 July 2025, has substantially offset dispensing volume losses for most pharmacies. The 8CPA provides CPI-indexed remuneration certainty through to June 2029. The more significant design implication of 60-day dispensing is what it frees pharmacists to do - fewer routine repeat transactions creates time and space for clinical consultations. The pharmacies investing in consultation rooms now are positioning for the revenue that expanded scope services will generate, not retreating from what 60-day scripts have reduced.

  • A builder's construction quote covers physical fitout works only - not design fees, pharmacy equipment, or regulatory submissions. Professional design and documentation, dispensing robots and automation, medical-grade refrigeration, point-of-sale systems, retail fixtures, building permits, pharmacy authority plan preparation, and engineering consultants are all outside the construction contract. The total project investment is typically 20 to 40 per cent above the construction quote alone, and more for specialist environments such as sterile compounding suites.

  • Sterile compounding is the highest cost fitout category in pharmacy. The HVAC system alone - dedicated air handling unit, HEPA filtration, and cleanroom pressure management - typically costs $25,000 to $70,000 depending on the ISO air classification required. Cleanroom construction, specialist equipment, water purification, environmental monitoring, and TGA GMP validation are all additional. The Pharmacy Board's compounding guidelines that took effect in October 2024 require a documented facility risk assessment before commencing any compounding - engaging a pharmacy designer with cleanroom experience at the briefing stage is the most reliable way to ensure the fitout scope reflects what the guidelines require.

  • The main variables are documentation completeness, building approval pathway, existing building condition, and contractor availability. In markets with strong construction demand - particularly Brisbane, Perth, and Adelaide in 2026 - contractor booking lead times have extended due to labour and project pipeline pressures. Building approvals for standard fitout certification typically move faster than full building permits, but the pathway depends on the scope of works and state-specific requirements. Engaging a designer early in the process - well before a lease is signed - gives the documentation phase the time it needs to avoid delays that compress the construction program.

Next
Next

How to Choose a Salon Interior Designer (and Why It's Not Like Hiring Any Designer)